Cargando…

Possible Targets of Pan-Coronavirus Antiviral Strategies for Emerging or Re-Emerging Coronaviruses

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), which caused Coronaviruses Disease 2019 (COVID-19) and a worldwide pandemic, is the seventh human coronavirus that has been cross-transmitted from animals to humans. It can be predicted that with continuous contact between humans and anim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xue, Zhang, Liying, Chen, Si, Ouyang, Hongsheng, Ren, Linzhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306356/ https://www.ncbi.nlm.nih.gov/pubmed/34361915 http://dx.doi.org/10.3390/microorganisms9071479

Ejemplares similares

Emerging and re-emerging coronaviruses in pigs
por: Wang, Qiuhong, et al.
Publicado: (2019)

Flavonoids as Potential Antiviral Agents for Porcine Viruses
por: Zhang, Xinwei, et al.
Publicado: (2022)

Reverse Genetics Systems for Emerging and Re-Emerging Swine Coronaviruses and Applications
por: Jiang, Hui, et al.
Publicado: (2023)

Coronaviruses: emerging and re-emerging pathogens in humans and animals
por: Lau, Susanna K. P., et al.
Publicado: (2015)

A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses
por: Zheng, Yucheng, et al.
Publicado: (2022)

RIG-I-Like Receptors as Novel Targets for Pan-Antivirals and Vaccine Adjuvants Against Emerging and Re-Emerging Viral Infections
por: Yong, Hui Yee, et al.
Publicado: (2018)

Conserved Targets to Prevent Emerging Coronaviruses
por: Gonzalez Lomeli, Fernanda, et al.
Publicado: (2022)

Indomethacin-based PROTACs as pan-coronavirus antiviral agents
por: Desantis, Jenny, et al.
Publicado: (2021)

Repurposing dyphylline as a pan-coronavirus antiviral therapy
por: Wang, Yining, et al.
Publicado: (2022)

Natural Flavonoid Derivatives Have Pan-Coronavirus Antiviral Activity
por: Mori, Mattia, et al.
Publicado: (2023)

Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines
por: Jiang, Shibo, et al.
Publicado: (2012)

Necessary problems in re-emergence of COVID-19
por: Chen, Si, et al.
Publicado: (2021)

Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species
por: Li, Chun, et al.
Publicado: (2020)

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
por: Chan, Jasper F.W., et al.
Publicado: (2013)

Current understanding on molecular drug targets and emerging treatment strategy for novel coronavirus-19
por: Raj, Khadga, et al.
Publicado: (2021)

Host resilience to emerging coronaviruses
por: Jamieson, Amanda M
Publicado: (2016)

A molecular arms race between host innate antiviral response and emerging human coronaviruses
por: Wong, Lok-Yin Roy, et al.
Publicado: (2016)

Coronavirus: An emergency for healthcare professionals
por: Verma, Sumit, et al.
Publicado: (2020)

Microfluidic-RT-LAMP chip for the point-of-care detection of emerging and re-emerging enteric coronaviruses in swine
por: Zhou, Ling, et al.
Publicado: (2020)

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
por: Pfefferle, Susanne, et al.
Publicado: (2011)

The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses
por: Tse, Longping V., et al.
Publicado: (2020)

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
por: She, Jun, et al.
Publicado: (2020)

Recent trends in click chemistry as a promising technology for virus-related research
por: Ouyang, Ting, et al.
Publicado: (2018)

Multiple antigenic peptide (MAP): a synthetic peptide dendrimer for diagnostic, antiviral and vaccine strategies for emerging and re-emerging viral diseases
por: Joshi, Vinay Ganeshrao, et al.
Publicado: (2013)

Molecular pathology of emerging coronavirus infections
por: Gralinski, Lisa E, et al.
Publicado: (2015)

Emerging coronavirus diseases and future perspectives
por: Akhter, Shireen, et al.
Publicado: (2020)

The history of the emergence and transmission of human coronaviruses
por: Mulabbi, Elijah N., et al.
Publicado: (2021)

Emerging Roles of Coronavirus in Autoimmune Diseases
por: Zhou, Si-Yu, et al.
Publicado: (2021)

Re-emerging Middle East respiratory syndrome coronavirus: The hibernating bat hypothesis
por: Fakhoury, Hana, et al.
Publicado: (2015)

A new threat from an old enemy: Re-emergence of coronavirus (Review)
por: Docea, Anca Oana, et al.
Publicado: (2020)

Re-emergence of coronavirus disease in Chinese cities associated with chilled and frozen food products
por: Xie, Yongsheng, et al.
Publicado: (2021)

Corrigendum to ‘genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species’ [Infect. Genet. Evol. 82 (2020) 104285]
por: Ren, Linzhu, et al.
Publicado: (2021)

Nano‐therapeutic strategies to target coronavirus
por: Rauf, Mohd Ahmar, et al.
Publicado: (2021)

Feline Coronavirus Antivirals: A Review
por: Delaplace, Manon, et al.
Publicado: (2021)

Recent Progress on Epidemiology and Pathobiology of Porcine Circovirus 3
por: Chen, Si, et al.
Publicado: (2021)

Advances in Crosstalk between Porcine Circoviruses and Host
por: Niu, Guyu, et al.
Publicado: (2022)

Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses
por: Touati, Rabeb, et al.
Publicado: (2020)

Re-emergence of Severe Acute Diarrhea Syndrome Coronavirus (SADS-CoV) in Guangxi, China, 2021
por: Sun, Yankuo, et al.
Publicado: (2022)

Special Issue “State-of-the-Art Porcine Virus Research in China”
por: Ouyang, Hongsheng, et al.
Publicado: (2023)

A decade after SARS: strategies for controlling emerging coronaviruses
por: Graham, Rachel L., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jeue06f8nkivkn9ihlukj7tkj8